- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07733960
Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer (CSP Display)
24. juli 2026 opdateret af: Medtronic Cardiac Rhythm and Heart Failure
The purpose of this study is to collect and compare the heart's electrical activity data measured by the novel Conduction System Pacing (CSP) Display Research System with data measured via 12 lead electrocardiogram (ECG) from a commercially available, standard of care electro-physiology (EP) monitoring and recording device during the pacemaker implantation.
Participants receiving a routine de-novo implantation of a pacemaker for left bundle branch area pacing (LBBAP) will undergo the CSP Display System protocol during the implant procedure.
Studieoversigt
Status
Rekruttering
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This feasibility study evaluates the use of the CSP Display Research System during single- or dual-chamber pacemaker implantation for left bundle branch area pacing (LBBAP).
The system provides visualization of electrocardiogram data and automatic measurement of left ventricular activation time.
Measurements using the CSP Display Research System will be compared with measurements obtained from a standard electrophysiology (EP) recording system used during the implant procedure as part of standard clinical practice.
This study also includes exploratory collection of electrocardiogram, intracardiac electrogram, pacemaker marker channel, and left ventricular activation time data during the implant procedure to support future research and algorithm development.
These data will be collected for exploratory purposes and do not have a pre-specified evaluation in this study.
Undersøgelsestype
Observationel
Tilmelding (Anslået)
100
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Sr Director - Clinical Research and Medical Science, Medtronic
- Telefonnummer: +91-2233074700
- E-mail: vinay.rajan@medtronic.com
Studiesteder
-
-
Tamil Nadu
-
Madurai, Tamil Nadu, Indien
- Rekruttering
- Velammal Medical College Hospital and Research Institute
-
Kontakt:
- Saravanakumar Govindasamy
- E-mail: vmc.cardiacresearch@gmail.com
-
Ledende efterforsker:
- Shunmuga Sundaram
-
-
Telegana
-
Hyderabad, Telegana, Indien
- Rekruttering
- Asian Institute of Gastroenterology(AIG) hospitals
-
Kontakt:
- Walli Mohammed
- E-mail: drwallimohammedaig@yahoo.com
-
Ledende efterforsker:
- Calambur Narasimhan, MD
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
The target population for the CSP Display study will include subjects who are indicated to receive a de-novo pacemaker implant (single or dual chamber) with left bundle branch area pacing (LBBAP) based on market approved indications.
Beskrivelse
Inclusion Criteria:
- Subject is at least 18 years of age
- Subject is willing and able to provide written informed consent
- Subject is willing and able to comply with the protocol
- Subject meets eligibility for de-novo implant of a pacemaker (single or dual chamber) with left bundle branch area pacing (LBBAP) therapy
Exclusion Criteria:
- Subject is not available to comply with visit schedule
- Pregnant or breastfeeding woman (pregnancy test required for woman of child-bearing potential and who are not on a reliable form of birth regulation method or abstinence)
- Subject is currently enrolled or planning to enroll in a concurrent study that may confound the results of this study. Pre-approval from the study manager is required for enrollment of a patient that is in a concurrent study.
- Subject meets any exclusion criteria required by local law
- Vulnerable adults (i.e. subjects incapable of giving consent)
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Patients receiving a clinically indicated single- or dual-chamber pacemaker implantation
Patients with left bundle branch area pacing will have measurements collected using the CSP Display Research System for visualisation of surface electrocardiogram data and automatic measurement of left ventricular activation time for comparison with a standard electrophysiology recording system.
|
Research system used during pacemaker implantation to visualize surface electrocardiogram data and automatically measure left ventricular activation time
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Left Ventricular Activation Time (LVAT)
Tidsramme: During pacemaker implant procedure
|
LVAT measured using the CSP Display Research System and a commercial electrophysiology recording system
|
During pacemaker implant procedure
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Surface ECG V1 morphology
Tidsramme: During pacemaker implant procedure
|
V1 morphology observed using the CSP Display Research System and a commercial electrophysiology recording system.
|
During pacemaker implant procedure
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
21. maj 2026
Primær færdiggørelse (Anslået)
30. juli 2027
Studieafslutning (Anslået)
30. juli 2027
Datoer for studieregistrering
Først indsendt
18. maj 2026
Først indsendt, der opfyldte QC-kriterier
24. juli 2026
Først opslået (Faktiske)
29. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
29. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
24. juli 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CSP Display Study
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ja
produkt fremstillet i og eksporteret fra U.S.A.
Ja
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .